Differential characteristics of empagliflozin in the treatment of diabetes mellitus

Article

Abstract: t present, diabetes mellitus (DM) is responsible for a large proportion of the total morbidity and m

Palabras claves:

Blood pressure, Body weight, diabetes mellitus, Empagliflozin, SGLT2 inhibitors

Autores:

Adriana Victoria López Pino, Benavides K.M.R., Egas C.M.A., Estefanía Carolina Santamaría Loza, González M.D.M., Gutiérrez A.M.V., Mena D.S.T., Moreira V.D.A., Villacrés V.Z.C.

Fuentes:

scopus